Sultan
Right atrial myxoma in a patient with Budd‑Chiari syndrome (RCD code: VI‑1A.1) Fateh Ali Tipoo Sultan, Bilal Hussain, Faiza Rasheed Full Text: PDF Abstract Budd‑Chiari syndrome (BCS) is a rare clinical disorder which is caused by obstruction of the major hepatic veins or suprahepatic portion of the inferior vena cava. Either thrombosis or a mechanical […]
Hussain
A rare case of atypical mid‑variant takotsubo cardiomyopathy during dobutamine stress echocardiography (RCD code: III‑5B) Bilal Hussain, Nageeb Basir Full Text: PDF Abstract Dobutamine stress echo (DSE) allows for a relatively safe and accurate assessment of ischaemia in patients, who are unable to exercise. Side effects of DSE include nausea, vomiting, and in certain cases, […]
Serra
Biventricular cardiomyopathy improvement by shifting therapy from agalsidase alfa to agalsidase beta in Anderson‑Fabry Disease (RCD code: III‑3B.2) Walter Serra, Guido Pastorini Full Text: PDF Abstract Treatment of Fabry disease has improved since the introduction of enzyme replacement therapy (ERT). Two preparations of the recombinant enzyme α‑galactosidase A are available: agalsidase alfa and agalsidase beta. […]
Ząbek
Pregnancy and congenital complete atrioventricular block: management during pregnancy and periparturient period (RCD code: VII-V) Andrzej Ząbek, Barbara Małecka, Paweł Tomasz Matusik, Maciej Dębski, Krzysztof Boczar, Jacek Lelakowski Full Text: PDF Abstract Complete atrioventricular block (AVB) is rare during pregnancy. Congenital atrioventricular block is the most common type of heart block in this group of […]
Nowak
Effect of first‑month specific therapy determines long‑term clinical outcome in patients with pulmonary arterial hypertension (RCD code: II‑1A.4.o) Adrianna Nowak, Karolina Bula, Karol Głowacki, Wojciech Gawin, Marcin Kalita, Konstantinos Nechoritis, Marek Grabka, Katarzyna Mizia-Stec Full Text: PDF Abstract Background: Efficacy of pulmonary arterial hypertension (PAH)-specific therapy may differ among the patients depending on the PAH aetiology. […]
Iwańczyk
Pulmonary arterial hypertension: management in specific medical conditions (RCD code: II‑1A.1) Sylwia Iwańczyk, Tatiana Mularek-Kubzdela Full Text: PDF Abstract Pulmonary arterial hypertension (PAH) is a severe and progressive disease. Due to the narrowing of the blood vessels in the lungs, pul- monary vascular resistance and pulmonary pressures increase. This results in reduced cardiac output, right […]
Komar
Cardiac Tumours and Malignancy Diseases Monika Komar Full Text: PDF Abstract n/a DOI: http://dx.doi.org/10.20418%2Fjrcd.vol3no6.323 Refbacks There are currently no refbacks.
Podolec
Introduction Piotr Podolec Full Text: PDF Abstract n/a DOI: http://dx.doi.org/10.20418%2Fjrcd.vol3no6.321 Refbacks There are currently no refbacks.
